Clinical Trial Update: Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing vildagliptin to glimepiride as add-on to metformin in type 2 diabetes; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED